News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
338,951 Results
Type
Article (20479)
Company Profile (129)
Press Release (318333)
Multimedia
Podcasts (91)
Webinars (15)
Section
Business (105624)
Career Advice (886)
Deals (18578)
Drug Delivery (100)
Drug Development (50902)
Employer Resources (79)
FDA (7759)
Job Trends (7787)
News (186368)
Policy (17418)
Tag
Academia (736)
Accelerated approval (9)
Adcomms (21)
Allergies (54)
Alliances (27966)
ALS (67)
Alzheimer's disease (709)
Antibody-drug conjugate (ADC) (122)
Approvals (7807)
Artificial intelligence (194)
Autoimmune disease (24)
Automation (8)
Bankruptcy (178)
Best Places to Work (5554)
BIOSECURE Act (13)
Biosimilars (117)
Biotechnology (57)
Bladder cancer (54)
Brain cancer (26)
Breast cancer (159)
Cancer (1537)
Cardiovascular disease (149)
Career advice (722)
Career pathing (21)
CAR-T (69)
CDC (8)
Cell therapy (188)
Cervical cancer (8)
Clinical research (43473)
Collaboration (654)
Compensation (258)
Complete response letters (31)
COVID-19 (1123)
CRISPR (34)
C-suite (269)
Cystic fibrosis (71)
Data (1801)
Decentralized trials (2)
Denatured (23)
Depression (44)
Diabetes (183)
Diagnostics (1839)
Digital health (8)
Diversity (7)
Diversity, equity & inclusion (22)
Drug discovery (106)
Drug pricing (148)
Drug shortages (33)
Duchenne muscular dystrophy (96)
Earnings (40123)
Editorial (35)
Employer branding (10)
Employer resources (75)
Events (49532)
Executive appointments (561)
FDA (8781)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (3)
Frontotemporal dementia (2)
Funding (444)
Gene editing (63)
Generative AI (19)
Gene therapy (192)
GLP-1 (697)
Government (1940)
Grass and pollen (4)
Guidances (172)
Healthcare (5914)
HIV (20)
Huntington's disease (16)
IgA nephropathy (34)
Immunology and inflammation (120)
Immuno-oncology (11)
Indications (29)
Infectious disease (1219)
Inflammatory bowel disease (96)
Inflation Reduction Act (10)
Influenza (30)
Intellectual property (86)
Interviews (116)
IPO (7402)
IRA (52)
Job creations (2439)
Job search strategy (650)
Kidney cancer (8)
Labor market (43)
Layoffs (311)
Leadership (19)
Legal (4138)
Liver cancer (34)
Longevity (6)
Lung cancer (232)
Lymphoma (137)
Machine learning (6)
Management (30)
Manufacturing (323)
MASH (70)
Medical device (1982)
Medtech (1985)
Mergers & acquisitions (11539)
Metabolic disorders (643)
Multiple sclerosis (64)
NASH (20)
Neurodegenerative disease (75)
Neuropsychiatric disorders (31)
Neuroscience (1155)
NextGen: Class of 2025 (2360)
Non-profit (911)
Now hiring (34)
Obesity (387)
Opinion (209)
Ovarian cancer (45)
Pain (98)
Pancreatic cancer (64)
Parkinson's disease (103)
Partnered (12)
Patents (202)
Patient recruitment (100)
Peanut (18)
People (33906)
Pharmaceutical (74)
Pharmacy benefit managers (25)
Phase I (13635)
Phase II (18369)
Phase III (14762)
Pipeline (1336)
Policy (189)
Postmarket research (1619)
Preclinical (4790)
Press Release (29)
Prostate cancer (93)
Psychedelics (19)
Radiopharmaceuticals (168)
Rare diseases (325)
Real estate (3184)
Recruiting (30)
Regulatory (12940)
Reports (25)
Research institute (823)
Resumes & cover letters (139)
Rett syndrome (2)
RNA editing (7)
RSV (31)
Schizophrenia (83)
Series A (81)
Series B (49)
Service/supplier (7)
Sickle cell disease (43)
Special edition (18)
Spinal muscular atrophy (112)
Sponsored (15)
Startups (2025)
State (2)
Stomach cancer (10)
Supply chain (63)
Tariffs (76)
The Weekly (66)
Vaccines (336)
Venture capital (43)
Weight loss (280)
Women's health (19)
Worklife (8)
Date
Today (14)
Last 7 days (238)
Last 30 days (1213)
Last 365 days (15901)
2025 (10196)
2024 (17673)
2023 (19637)
2022 (25866)
2021 (26640)
2020 (24872)
2019 (20060)
2018 (15589)
2017 (17253)
2016 (16202)
2015 (18801)
2014 (14787)
2013 (12552)
2012 (13482)
2011 (13817)
2010 (12738)
Location
Africa (412)
Alabama (30)
Alaska (1)
Arizona (76)
Arkansas (8)
Asia (25316)
Australia (3261)
California (3482)
Canada (1432)
China (489)
Colorado (135)
Connecticut (137)
Delaware (116)
Europe (52311)
Florida (625)
Georgia (79)
Hawaii (1)
Idaho (17)
Illinois (335)
India (27)
Indiana (217)
Iowa (3)
Japan (186)
Kansas (72)
Kentucky (24)
Louisiana (3)
Maine (4)
Maryland (472)
Massachusetts (2915)
Michigan (55)
Minnesota (183)
Mississippi (3)
Missouri (32)
Montana (10)
Nebraska (11)
Nevada (27)
New Hampshire (8)
New Jersey (1391)
New Mexico (21)
New York (991)
North Carolina (617)
North Dakota (2)
Northern California (1495)
Ohio (99)
Oklahoma (6)
Oregon (21)
Pennsylvania (814)
Puerto Rico (15)
Rhode Island (20)
South America (610)
South Carolina (6)
Southern California (1456)
Tennessee (48)
Texas (475)
United States (13678)
Utah (75)
Virginia (132)
Washington D.C. (54)
Washington State (278)
West Virginia (1)
Wisconsin (32)
338,951 Results for "dexcel pharma".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Venture capital
Building Pharma’s Farm System: Eli Lilly, Boehringer Ingelheim, More Invest in the Future
While a substantial portion of pipeline assets are externally sourced, many Big Pharmas are tapping into incubators and venture funds to uncover cutting-edge scientific trends, determine their future focus points and even carve out a niche in an emerging geographical hotspot.
August 6, 2025
·
5 min read
·
Heather McKenzie
Job Trends
Amidst Industry Challenges, 85% of Pharmas Increase Investment in AI
A new report found that 85% of pharma respondents are increasing their artificial intelligence investments, and 70% see AI as an immediate priority. Two experts discuss how biopharmas are implementing and adopting AI, including their increased use of external help with the process.
July 31, 2025
·
4 min read
·
Angela Gabriel
Earnings
AstraZeneca CEO Says World ‘Needs to Share’ in Global Pharma R&D
Pascal Soriot’s comments came during AstraZeneca’s Q2 earnings call in regard to President Donald Trump’s newly announced European pharma tariffs. The company also announced estimate-beating earnings, with its cancer portfolio driving earnings despite clinical roadblocks.
July 29, 2025
·
3 min read
·
Tristan Manalac
Deals
Revolution Establishes Endless Cash Runway With $2B Royalty Pharma Deal
In May, Revolution Medicines projected its cash and equivalents of $2.1 billion would last into the second half of 2027. With new funding from Royalty Pharma, the biotech has withdrawn that runway end date.
June 24, 2025
·
1 min read
·
Annalee Armstrong
Clinical research
Undeterred by Political, Economic Headwinds, Pharma Ups R&D Investment in 2024 and Beyond
R&D spending across the global pharmaceutical sector climbed 1.5% in 2024, according to unreleased data from Evaluate Pharma.
May 28, 2025
·
12 min read
·
Tristan Manalac
Tariffs
Trump Threatens Highest Pharma Tariffs So Far at 250%
President Donald Trump plans to start with a “small tariff” on pharmaceutical imports before ramping duties up to 250% within a year and a half.
August 6, 2025
·
2 min read
·
Tristan Manalac
Government
Trump Tariffs Miss Pharma For Now, But Uncertainties Loom
Pharma’s reprieve from Donald Trump’s tariffs is expected to be temporary, with Leerink analysts anticipating possible sector-specific duties “in the next month or so.”
April 3, 2025
·
2 min read
·
Tristan Manalac
Manufacturing
FDA Launches New PreCheck Program to Lower Regulatory Barriers to Pharma Manufacturing
Under PreCheck, the FDA will communicate more frequently with pharmaceutical companies, helping them as they establish or expand manufacturing sites in the U.S.
August 8, 2025
·
2 min read
·
Tristan Manalac
Brain Cancer
Glioblastoma Funding Rises as Nonprofits Drive Interest and Pharma Returns to the Table
After decades of limited progress—owing to the difficulty of treating the disease and resultant market risk—glioblastoma research is entering a new phase spurred by smarter trials, targeted funding and renewed interest from companies like Merck and Jazz Pharmaceuticals.
August 4, 2025
·
6 min read
·
Ben Hargreaves
Opinion
How AI Can Help Pharma Companies Adapt to Policy Pressures
The regulatory environment is placing extreme pricing pressure on pharmaceutical manufacturers. Their success in the market depends on mounting an agile response.
August 6, 2025
·
5 min read
·
Jesse Mendelsohn
1 of 33,896
Next
